Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-081751
Filing Date
2025-08-28
Accepted
2025-08-28 16:15:26
Documents
3
Period of Report
2025-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K ea0254405-6k_ascentage.htm 6-K 11415
2 PRESS RELEASE DATED AUGUST 25, 2025 ea025440501ex99-1_ascentage.htm EX-99.1 13512
3 GRAPHIC ex99-1_001.jpg GRAPHIC 19184
  Complete submission text file 0001213900-25-081751.txt   52607
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU F4 00000 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42484 | Film No.: 251273636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)